Action of TCM prescriptions and natural bioactive molecules in atherosclerosis therapy by targeting peroxisome proliferator-activated receptors (PPARs)
Mechanisms of action of TCM prescriptions and natural bioactive molecules in atherosclerosis therapy by targeting peroxisome proliferator-activated receptors (PPARs). TCM prescriptions and natural bioactive molecules including flavonoids, natural acids, alkaloids, terpenoids, and phenolic compounds mainly decreases lipid accumulation by activating AMP-activated protein kinase (AMPK) and the subsequent signaling pathways including PPARα/carnitine palmitoyl transferase (CPT)-1 and acyl-CoA oxidase 1 (ACOX1)-mediated fatty acid β-oxidation in liver and PPARγ/liver X receptor (LXR) α/ATP-binding cassette transporter (ABC) A1/ABCG1-mediated cholesterol efflux from macrophages to apolipoprotein (Apo) A1 and high-density lipoprotein (HDL) particles, thereby decreasing foam cell formation. Moreover, some TCM prescriptions and natural molecules may decrease cluster of differentiation (CD) 36-mediated lipid absorption via suppressing PPARγ, thereby reducing lipid accumulation in macrophages. Notably, TCM prescriptions and natural molecules primarily ameliorate inflammation by suppressing mitogen-activated protein kinase (MAPK)/nuclear factor kappa B (NK-κB) and phosphoinositide-3 kinase (PI3K)/protein kinase B (AKT/PKB)/NK-κB signaling pathways through activation of PPARγ. Furthermore, these natural compounds can inhibit Toll-like receptor (TLR)4/myeloid differentiation factor 88 (MyD88)/NF-κB signaling pathway and promote macrophage shift to an anti-inflammatory M2 type through activation of PPARα. Notably, natural compounds may stimulate PPARγ coactivator (PGC)-1β–estrogen related receptor α to activate PPARβ/PPARγ signaling pathways and enhance protein kinase A (PKA)/AMPK signaling pathway to upregulate PPARα in the liver. Except for NF-κB, nuclear transcription factor activator protein 1 (AP-1) is involved in the modulatory effects of PPARs on anti-inflammation. These beneficial effects of TCMs are supposed to retard the development of atherosclerosis. IKK: inhibitor of nuclear factor κB kinase subunit; IL: interleukin; TNF-α: tumor necrosis factor α
Publication
Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation (2024) Yan Zhang, et al. Front Cardiovasc Med. 2024;11(NA). Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAA1 | 5562 |
| Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAA2 | 5563 |
| Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAB1 | 5564 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAB2 | 5565 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG1 | 5571 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG2 | 51422 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG3 | 53632 |
| Homo sapiens | Primates | HDL | HDL | ncbigene_synonym | HSD11B1 | 3290 |
| Homo sapiens | Primates | HDL | HDL | famplex_relations | ALB | 213 |
| Homo sapiens | Primates | HDL | HDL | famplex_relations | APOA1 | 335 |
| Homo sapiens | Primates | HDL | HDL | famplex_relations | APOA2 | 336 |
| Homo sapiens | Primates | HDL | HDL | famplex_relations | APOE | 348 |
| Homo sapiens | Primates | HDL | HDL | famplex_relations | CLU | 1191 |
| Homo sapiens | Primates | ABCG1 | ABCG1 | ncbigene_symbol | ABCG1 | 9619 |
| Homo sapiens | Primates | PPARa/y | PPARA | ncbigene_symbol | PPARA | 5465 |
| Homo sapiens | Primates | PPAR | PPAR | famplex_relations | PPARD | 5467 |
| Homo sapiens | Primates | PPAR | PPAR | famplex_relations | PPARG | 5468 |
| Homo sapiens | Primates | LXRa | LXRA | ncbigene_synonym | NR1H3 | 10062 |
| Homo sapiens | Primates | ABCA1 | ABCA1 | ncbigene_symbol | ABCA1 | 19 |
| Homo sapiens | Primates | ACOX1 | ACOX1 | ncbigene_symbol | ACOX1 | 51 |
| Homo sapiens | Primates | CPT-1a | CPT1A | ncbigene_symbol | CPT1A | 1374 |
| Homo sapiens | Primates | CD36 | CD36 | ncbigene_symbol | CD36 | 948 |
| Homo sapiens | Primates | TLR2 | TLR2 | ncbigene_symbol | TLR2 | 7097 |
| Homo sapiens | Primates | TLR4 | TLR4 | ncbigene_symbol | TLR4 | 7099 |
| Homo sapiens | Primates | MyD88 | MYD88 | ncbigene_symbol | MYD88 | 4615 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK1 | 5594 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK3 | 5595 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK11 | 5600 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK12 | 6300 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK13 | 5603 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK14 | 1432 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK8 | 5599 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK9 | 5601 |
| Homo sapiens | Primates | MAPK | MAPK | famplex_relations | MAPK10 | 5602 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | IRE-1 | IRE1 | ncbigene_synonym | ERN1 | 2081 |
| Homo sapiens | Primates | AP-1 | AP-1 | ncbigene_synonym | FOS | 2353 |
| Homo sapiens | Primates | AP-1 | AP-1 | ncbigene_synonym | FOSB | 2354 |
| Homo sapiens | Primates | AP-1 | AP-1 | ncbigene_synonym | JUN | 3725 |
| Homo sapiens | Primates | AP-1 | AP-1 | ncbigene_synonym | JUNB | 3726 |
| Homo sapiens | Primates | AP-1 | AP-1 | ncbigene_synonym | JUND | 3727 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| medicine | medicine | chebi:23888 | ||
| HDL | HDL | chebi:39025 | ||
| Cholesterol | cholesterol | cholesterol | chebi:16113 | |
| Fatty acid | Fatty acid | fatty acids | chebi:35366 | |
| Alkaloid | Alkaloid | alkaloids | chebi:22315 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| Atherosclerosis | atherosclerosis | atherosclerosis | DOID:1936 |